IMO , if results are good in phase 2 TNBC , it will be approve for this indication very fast , when FDA want to do something , they know how to do things very fast , and Leronlimab is not a new medicine for them ..,and TNBC is a terrible cancer , so let’s just start with injections ..
We really should have some explanation what is happening with it ....

FDA recommended expanded access program , company will need to provide medicine with other cancers, but for the very sick not responding to anything else .